General MedicationsINTRAVENOUSGeneric

TRIFERIC

FERRIC PYROPHOSPHATE CITRATE

Standard Dose

27.2MG IRON/5ML (5.44MG IRON/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview TRIFERIC is listed in Drugs@FDA under application 206317 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient FERRIC PYROPHOSPHATE CITRATE Form and strength SOLUTION;INTRAVENOUS - 27.2MG IRON/5ML (5.44MG IRON/ML) Sponsor ROCKWELL MEDICAL INC Submission history Latest submission status date: 2019-07-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRIFERIC is listed in Drugs@FDA under application 206317 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient FERRIC PYROPHOSPHATE CITRATE Form and strength SOLUTION;INTRAVENOUS - 27.2MG IRON/5ML (5.44MG IRON/ML) Sponsor ROCKWELL MEDICAL INC Submission history Latest submission status date: 2019-07-10 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.